Rajesh Prasad, MD
Cardiovascular Disease (Cardiology) · Morgan Hill
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 28
- 8 carriers
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
28 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Prasad’s office at (408) 778-7248 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
28 of 28 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A50724 · Current
Licensed to practise in California · since 1992 · expires 2027-10-31 · University of Madras, Madras Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$469,840
Medicare paid this office $469,840 for 714 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 620 | $147,045 | $107 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 138 | $117,818 | $848 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 275 | $48,805 | $175 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 189 | $41,962 | $222 |
| Ultrasound of both sides of head and neck blood flow | 154 | $27,682 | $180 |
See all 14 services
| Return visit (30+ min) | 620 | $147,045 | $107 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 138 | $117,818 | $848 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 275 | $48,805 | $175 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 189 | $41,962 | $222 |
| Ultrasound of both sides of head and neck blood flow | 154 | $27,682 | $180 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 86 | $25,224 | $66 |
| New patient visit (45+ min) | 154 | $19,961 | $130 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 91 | $11,271 | $109 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 122 | $7,574 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 416 | $5,836 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 84 | $5,131 | $61 |
| Programming of dual lead pacemaker system | 33 | $4,093 | $64 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 137 | $2,947 | $21 |
| External shock to heart to regulate heart beat | 12 | $1,195 | $92 |
Procedures Medicare counted
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
714 Original Medicare patients in 2024. Average age 78 · Under 65 2% · 85 and older 20% · Women 51% · Also on Medicaid 14% · Health risk score 1.58. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Atrial fibrillation 39% · Diabetes 38% · Coronary heart disease 36% · Heart failure 30% · Chronic kidney disease 29% · Depression 19% · Stroke 17% · COPD 15% · Cancer 14% · Dementia 10%.
The office billed $1,336,970, Medicare allowed $633,141 and paid $469,840; for 3,722 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 714 | 3,722 | 78 | 1.58 | $1,336,970 | $469,840 |
| 2023 | 743 | 3,806 | 78 | 1.44 | $1,391,453 | $535,898 |
| 2022 | 858 | 4,009 | 78 | 1.53 | $1,293,683 | $453,064 |
| 2021 | 854 | 3,777 | 77 | 1.64 | $1,316,824 | $449,024 |
| 2020 | 780 | 3,352 | 77 | 1.59 | $969,289 | $352,098 |
| 2019 | 906 | 4,645 | 77 | 1.58 | $1,396,442 | $490,832 |
| 2018 | 824 | 4,729 | 77 | 1.58 | $1,389,704 | $490,210 |
| 2017 | 821 | 4,901 | 77 | 1.61 | $1,459,676 | $534,837 |
| 2016 | 828 | 4,591 | 77 | 1.54 | $1,368,141 | $501,384 |
| 2015 | 1,031 | 5,171 | 76 | 1.80 | $1,415,833 | $520,710 |
| 2014 | 858 | 5,297 | 77 | 1.49 | $1,559,320 | $574,836 |
| 2013 | 844 | 5,195 | 77 | 1.63 | $1,530,570 | $525,518 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Return visit (30+ min) | 622 | $152,113 | $116 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 130 | $120,324 | $926 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 319 | $62,998 | $196 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 201 | $46,041 | $229 |
| Ultrasound of both sides of head and neck blood flow | 182 | $35,756 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 55 | $28,513 | $107 |
| New patient visit (45+ min) | 173 | $25,932 | $150 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $17,537 | $71 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $9,958 | $156 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 115 | $7,649 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 413 | $6,346 | $14 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 48 | $6,076 | $117 |
| Programming of dual lead pacemaker system | 35 | $4,703 | $78 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 127 | $2,929 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 35 | $2,492 | $71 |
2022: 16 services
| Return visit (30+ min) | 653 | $155,967 | $111 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 323 | $64,557 | $198 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 264 | $61,959 | $234 |
| Ultrasound of both sides of head and neck blood flow | 172 | $33,883 | $196 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 96 | $30,420 | $92 |
| New patient visit (45+ min) | 155 | $23,411 | $151 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 113 | $21,946 | $178 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 18 | $17,666 | $981 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 142 | $9,169 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 496 | $7,246 | $13 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 76 | $5,127 | $67 |
| Programming of dual lead pacemaker system | 45 | $4,970 | $73 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 121 | $2,859 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 121 | $1,781 | $14 |
| External shock to heart to regulate heart beat | 15 | $1,501 | $100 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 16 | $374 | $23 |
2021: 15 services
| Return visit (30+ min) | 638 | $172,703 | $113 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 313 | $76,539 | $244 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 322 | $66,180 | $202 |
| Ultrasound of both sides of head and neck blood flow | 182 | $36,741 | $201 |
| New patient visit (45+ min) | 144 | $21,441 | $149 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 71 | $13,394 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $12,936 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 189 | $12,357 | $62 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 144 | $9,899 | $68 |
| Programming of dual lead pacemaker system | 48 | $5,771 | $74 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 315 | $5,027 | $14 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 82 | $2,149 | $25 |
| Heart rhythm recording of continous external ekg over 8-15 days | 87 | $1,543 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 21 | $1,537 | $73 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,133 | $67 |
2020: 14 services
| Return visit (30+ min) | 614 | $162,331 | $97 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 279 | $58,584 | $208 |
| Ultrasound of both sides of head and neck blood flow | 133 | $27,458 | $206 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 96 | $18,468 | $190 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 211 | $16,754 | $76 |
| New patient visit (45+ min) | 89 | $12,020 | $135 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $11,341 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 42 | $11,113 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 149 | $10,170 | $66 |
| Programming of dual lead pacemaker system | 53 | $6,197 | $65 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 279 | $4,739 | $15 |
| New patient visit (60+ min) | 11 | $2,210 | $201 |
| Short return visit (20+ min) | 14 | $1,023 | $73 |
| Ultrasound study of arm and leg arteries | 13 | $606 | $47 |
2019: 16 services
| Return visit (30+ min) | 715 | $165,521 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 361 | $73,187 | $202 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 265 | $61,310 | $231 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 118 | $34,123 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 133 | $27,264 | $181 |
| New patient visit (45+ min) | 187 | $26,501 | $142 |
| Ultrasound of both sides of head and neck blood flow | 137 | $26,275 | $192 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 236 | $19,075 | $78 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 182 | $12,168 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 580 | $10,329 | $16 |
| Programming of dual lead pacemaker system | 56 | $5,144 | $60 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 12 | $4,849 | $404 |
| Ultrasound study of arm and leg arteries | 56 | $4,739 | $85 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 19 | $4,675 | $246 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 43 | $2,854 | $66 |
| External shock to heart to regulate heart beat | 17 | $1,913 | $101 |
2018: 16 services
| Return visit (30+ min) | 672 | $193,186 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 375 | $78,595 | $207 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 247 | $54,956 | $222 |
| Ultrasound of both sides of head and neck blood flow | 155 | $30,828 | $199 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 88 | $23,838 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 106 | $21,494 | $179 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 255 | $20,985 | $80 |
| New patient visit (45+ min) | 134 | $18,636 | $139 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 147 | $10,064 | $63 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 517 | $9,196 | $15 |
| Programming of dual lead pacemaker system | 58 | $4,945 | $49 |
| Ultrasound study of arm and leg arteries | 53 | $4,213 | $79 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 14 | $3,471 | $248 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 53 | $3,357 | $63 |
| External shock to heart to regulate heart beat | 11 | $1,186 | $99 |
| Programming of single lead pacemaker system | 11 | $800 | $42 |
2017: 17 services
| Return visit (30+ min) | 662 | $207,341 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 415 | $94,606 | $225 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 320 | $82,923 | $258 |
| Ultrasound of both sides of head and neck blood flow | 113 | $22,117 | $194 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 94 | $19,827 | $175 |
| New patient visit (45+ min) | 145 | $19,494 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 71 | $18,605 | $92 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 214 | $17,707 | $79 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 169 | $9,158 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 505 | $9,089 | $15 |
| Programming of dual lead pacemaker system | 64 | $5,640 | $52 |
| Ultrasound study of arm and leg arteries | 64 | $5,270 | $81 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 21 | $4,505 | $215 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 39 | $2,867 | $72 |
| External shock to heart to regulate heart beat | 14 | $1,686 | $99 |
| Hospital discharge day management, 30 minutes or less | 11 | $795 | $66 |
| Programming of single lead pacemaker system | 11 | $677 | $40 |
2016: 18 services
| Return visit (30+ min) | 679 | $191,487 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 392 | $88,663 | $222 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 274 | $71,606 | $261 |
| Ultrasound of both sides of head and neck blood flow | 136 | $26,100 | $192 |
| New patient visit (45+ min) | 185 | $25,370 | $137 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 193 | $15,553 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $15,311 | $178 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 59 | $12,216 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 494 | $8,422 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 140 | $7,960 | $53 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 21 | $5,361 | $255 |
| Ultrasound study of arm and leg arteries | 55 | $4,643 | $84 |
| Programming of dual lead pacemaker system | 56 | $4,466 | $48 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 38 | $2,782 | $73 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,543 | $62 |
| Programming of single lead pacemaker system | 16 | $1,328 | $46 |
| External shock to heart to regulate heart beat | 11 | $1,218 | $101 |
| Hospital discharge day management, 30 minutes or less | 13 | $855 | $66 |
2015: 19 services
| Return visit (30+ min) | 632 | $194,448 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 379 | $85,918 | $226 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 290 | $79,541 | $270 |
| Ultrasound of both sides of head and neck blood flow | 163 | $33,599 | $205 |
| New patient visit (45+ min) | 164 | $23,546 | $144 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 190 | $16,092 | $83 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 160 | $10,121 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 72 | $9,964 | $65 |
| Ultrasound study of arm and leg arteries | 109 | $9,695 | $89 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 470 | $8,277 | $16 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $5,566 | $90 |
| Programming of dual lead pacemaker system | 57 | $5,268 | $54 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 20 | $4,562 | $228 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 355 | $4,056 | $8 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 32 | $3,913 | $122 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 23 | $2,153 | $90 |
| External shock to heart to regulate heart beat | 18 | $2,006 | $111 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 15 | $975 | $65 |
| Programming of single lead pacemaker system | 11 | $903 | $48 |
2014: 20 services
| Return visit (30+ min) | 668 | $201,212 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 427 | $97,331 | $225 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 314 | $86,579 | $273 |
| Ultrasound of both sides of head and neck blood flow | 181 | $33,355 | $184 |
| New patient visit (45+ min) | 240 | $32,268 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 101 | $17,438 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 118 | $15,549 | $89 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 191 | $15,301 | $80 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 199 | $12,942 | $56 |
| Ultrasound study of arm and leg arteries | 137 | $11,873 | $87 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 548 | $8,747 | $15 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $6,126 | $471 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 25 | $5,985 | $230 |
| Programming of dual lead pacemaker system | 63 | $5,081 | $49 |
| Critical care, first 30-74 minutes | 11 | $2,562 | $183 |
| Transitional care management services for problem of at least moderate complexity | 13 | $1,967 | $151 |
| External shock to heart to regulate heart beat | 14 | $1,703 | $106 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 27 | $1,319 | $35 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 18 | $1,091 | $61 |
| Programming of single lead pacemaker system | 15 | $1,035 | $45 |
2013: 20 services
| Return visit (30+ min) | 642 | $188,833 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 405 | $74,912 | $183 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 307 | $68,726 | $222 |
| Ultrasound of both sides of head and neck blood flow | 172 | $30,481 | $177 |
| New patient visit (45+ min) | 191 | $26,373 | $138 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 118 | $16,529 | $61 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 197 | $16,462 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 112 | $13,696 | $86 |
| Critical care, first 30-74 minutes | 67 | $13,681 | $187 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 224 | $13,361 | $53 |
| Ultrasound study of arm and leg arteries | 123 | $11,296 | $92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 500 | $8,903 | $17 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 29 | $7,546 | $252 |
| Programming of dual lead pacemaker system | 67 | $5,661 | $51 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $5,458 | $420 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 69 | $4,635 | $34 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 21 | $1,634 | $78 |
| External shock to heart to regulate heart beat | 12 | $1,511 | $108 |
| Programming of single lead pacemaker system | 18 | $1,223 | $41 |
| Hospital observation care on day of discharge | 14 | $894 | $64 |
Medicaid work
$8,284 in 2024
Medicaid paid $8,284 for 1,152 billed services this clinician did in 2024, up to 229 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 979 | $4,732 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 73 | $2,322 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 72 | $868 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 16 | $362 |
| Return visit (30+ min) | 12 | $0 |
| 2024 | 1,152 | 5 | 229 | $8,284 |
| 2023 | 1,079 | 3 | 204 | $6,288 |
| 2022 | 899 | 2 | 183 | $7,637 |
| 2021 | 540 | 2 | 150 | $4,816 |
| 2020 | 321 | 2 | 80 | $4,690 |
| 2019 | 57 | 2 | 38 | $697 |
| 2018 | 12 | 1 | 12 | $0 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 916 | $4,397 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 105 | $1,822 |
| Return visit (30+ min) | 58 | $69 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 790 | $5,040 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 109 | $2,597 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 493 | $3,851 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 47 | $966 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 269 | $3,273 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 52 | $1,417 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 43 | $502 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 14 | $195 |
2018
| Return visit (30+ min) | 12 | $0 |
Drugs they prescribed that Part D paid
$1,218,751
Pharmacies billed $1,218,751 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 4,399) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
3,553 generic and 846 brand-name prescriptions · $1,218,751 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 391 | $547,938 | $1,401 |
| Xarelto | 227 | $303,641 | $1,338 |
| Entresto | 71 | $116,728 | $1,644 |
| Jardiance | 25 | $41,046 | $1,642 |
| Farxiga | 24 | $40,721 | $1,697 |
See all 49 drugs
| Eliquis | 391 | $547,938 | $1,401 |
| Xarelto | 227 | $303,641 | $1,338 |
| Entresto | 71 | $116,728 | $1,644 |
| Jardiance | 25 | $41,046 | $1,642 |
| Farxiga | 24 | $40,721 | $1,697 |
| Repatha Sureclick | 21 | $20,647 | $983 |
| Dabigatran Etexilate | 32 | $13,525 | $423 |
| Edarbyclor | 16 | $7,260 | $454 |
| Metoprolol | 430 | $6,508 | $15 |
| Amiodarone | 216 | $6,193 | $29 |
| Propafenone | 78 | $5,497 | $70 |
| Diltiazem 24hr Er (Cd) | 108 | $5,395 | $50 |
| Nebivolol | 38 | $4,027 | $106 |
| Pitavastatin | 11 | $3,848 | $350 |
| Ezetimibe | 150 | $3,779 | $25 |
| Ranolazine Er | 18 | $3,639 | $202 |
| Rosuvastatin | 157 | $3,256 | $21 |
| Icosapent Ethyl | 15 | $2,945 | $196 |
| Atorvastatin | 300 | $2,900 | $10 |
| Carvedilol | 251 | $2,600 | $10 |
| Lisinopril | 151 | $2,048 | $14 |
| Amlodipine Besylate | 316 | $1,979 | $6 |
| Losartan | 164 | $1,891 | $12 |
| Spironolactone | 146 | $1,772 | $12 |
| Flecainide Acetate | 38 | $1,576 | $41 |
| Benazepril | 116 | $1,454 | $13 |
| Valsartan | 31 | $1,193 | $38 |
| Isosorbide Mononitrate Er | 45 | $1,148 | $26 |
| Clopidogrel | 88 | $961 | $11 |
| Hydralazine | 37 | $858 | $23 |
| Digoxin | 39 | $819 | $21 |
| Furosemide | 127 | $760 | $6 |
| Olmesartan Medoxomil | 23 | $548 | $24 |
| Verapamil Er | 14 | $545 | $39 |
| Cartia Xt | 15 | $460 | $31 |
| Sotalol | 23 | $459 | $20 |
| Fosinopril | 12 | $456 | $38 |
| Simvastatin | 27 | $431 | $16 |
| Bumetanide | 18 | $383 | $21 |
| Losartan-Hydrochlorothiazide | 28 | $383 | $14 |
| Warfarin | 23 | $280 | $12 |
| Irbesartan | 23 | $279 | $12 |
| Pravastatin | 16 | $259 | $16 |
| Clonidine | 12 | $258 | $22 |
| Nitroglycerin | 18 | $241 | $13 |
| Hydrochlorothiazide | 26 | $197 | $8 |
| Potassium Chloride | 11 | $157 | $14 |
| Irbesartan-Hydrochlorothiazide | 12 | $125 | $10 |
| Atenolol | 18 | $84 | $5 |
Year by year
| 2024 | 4,399 | 532 | 0% (0) | 19% | $1,218,751 |
| 2023 | 4,399 | 513 | 0% (0) | 19% | $1,175,853 |
| 2022 | 4,161 | 471 | 0% (0) | 20% | $1,018,038 |
| 2021 | 3,903 | 469 | 0% (0) | 20% | $812,338 |
| 2020 | 4,255 | 451 | 0% (0) | 20% | $780,984 |
| 2019 | 4,182 | 476 | 0% (0) | None | $671,661 |
| 2018 | 4,263 | 438 | 0% (0) | 19% | $521,391 |
| 2017 | 4,369 | 399 | 0% (0) | 20% | $416,788 |
| 2016 | 4,301 | 364 | None | 20% | $310,139 |
| 2015 | 3,966 | 352 | None | 25% | $273,370 |
| 2014 | 3,856 | 310 | 0% (0) | 24% | $235,801 |
| 2013 | 3,527 | 286 | 0% (0) | None | $176,054 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 52 drugs
| Eliquis | 344 | $479,176 | $1,393 |
| Xarelto | 209 | $286,644 | $1,372 |
| Entresto | 79 | $127,659 | $1,616 |
| Jardiance | 29 | $35,330 | $1,218 |
| Repatha Sureclick | 41 | $29,508 | $720 |
| Farxiga | 20 | $26,605 | $1,330 |
| Praluent | 16 | $12,486 | $780 |
| Dabigatran Etexilate | 28 | $11,865 | $424 |
| Brilinta | 12 | $9,917 | $826 |
| Diltiazem 24hr Er (Cd) | 109 | $8,559 | $79 |
| Metoprolol | 421 | $8,392 | $20 |
| Propafenone | 74 | $8,357 | $113 |
| Ezetimibe | 155 | $7,979 | $51 |
| Ranolazine Er | 17 | $6,592 | $388 |
| Icosapent Ethyl | 20 | $6,002 | $300 |
| Amiodarone | 140 | $5,854 | $42 |
| Edarbyclor | 11 | $4,935 | $449 |
| Atorvastatin | 285 | $4,567 | $16 |
| Rosuvastatin | 152 | $4,432 | $29 |
| Nebivolol | 25 | $4,264 | $171 |
| Carvedilol | 263 | $3,533 | $13 |
| Flecainide Acetate | 34 | $2,914 | $86 |
| Amlodipine Besylate | 311 | $2,826 | $9 |
| Lisinopril | 162 | $2,711 | $17 |
| Losartan | 163 | $2,439 | $15 |
| Benazepril | 143 | $2,074 | $15 |
| Irbesartan-Hydrochlorothiazide | 27 | $1,774 | $66 |
| Valsartan | 25 | $1,774 | $71 |
| Clopidogrel | 99 | $1,742 | $18 |
| Spironolactone | 126 | $1,608 | $13 |
| Isosorbide Mononitrate Er | 32 | $1,469 | $46 |
| Hydralazine | 54 | $1,370 | $25 |
| Sotalol | 29 | $1,370 | $47 |
| Digoxin | 42 | $1,318 | $31 |
| Bumetanide | 24 | $1,178 | $49 |
| Olmesartan Medoxomil | 30 | $1,061 | $35 |
| Valsartan-Hydrochlorothiazide | 13 | $992 | $76 |
| Furosemide | 150 | $868 | $6 |
| Nitroglycerin | 18 | $776 | $43 |
| Verapamil Er | 13 | $638 | $49 |
| Simvastatin | 35 | $630 | $18 |
| Irbesartan | 27 | $573 | $21 |
| Losartan-Hydrochlorothiazide | 25 | $548 | $22 |
| Fosinopril | 12 | $503 | $42 |
| Potassium Chloride | 22 | $495 | $23 |
| Warfarin | 22 | $427 | $19 |
| Pravastatin | 23 | $317 | $14 |
| Hydrochlorothiazide | 40 | $293 | $7 |
| Olmesartan-Hydrochlorothiazide | 11 | $225 | $20 |
| Atenolol | 17 | $224 | $13 |
| Metoprolol | 20 | $129 | $6 |
| Clonidine | 12 | $125 | $10 |
2022: 52 drugs
| Eliquis | 307 | $411,225 | $1,339 |
| Xarelto | 195 | $236,912 | $1,215 |
| Entresto | 69 | $107,630 | $1,560 |
| Repatha Sureclick | 52 | $31,310 | $602 |
| Multaq | 23 | $23,303 | $1,013 |
| Pradaxa | 19 | $20,411 | $1,074 |
| Praluent | 26 | $18,039 | $694 |
| Diltiazem 24hr Er (Cd) | 126 | $9,866 | $78 |
| Ezetimibe | 126 | $9,293 | $74 |
| Metoprolol | 408 | $9,187 | $23 |
| Ranolazine Er | 34 | $8,382 | $247 |
| Propafenone | 74 | $7,702 | $104 |
| Rosuvastatin | 163 | $7,486 | $46 |
| Icosapent Ethyl | 11 | $6,150 | $559 |
| Nebivolol | 24 | $4,107 | $171 |
| Atorvastatin | 291 | $4,101 | $14 |
| Flecainide Acetate | 33 | $3,565 | $108 |
| Carvedilol | 220 | $3,263 | $15 |
| Valsartan | 20 | $2,817 | $141 |
| Amlodipine Besylate | 278 | $2,706 | $10 |
| Amiodarone | 92 | $2,346 | $25 |
| Losartan | 164 | $2,041 | $12 |
| Lisinopril | 150 | $1,840 | $12 |
| Isosorbide Mononitrate Er | 49 | $1,827 | $37 |
| Clopidogrel | 83 | $1,679 | $20 |
| Hydralazine | 79 | $1,601 | $20 |
| Benazepril | 121 | $1,398 | $12 |
| Digoxin | 40 | $1,244 | $31 |
| Irbesartan-Hydrochlorothiazide | 19 | $1,174 | $62 |
| Spironolactone | 85 | $1,174 | $14 |
| Bumetanide | 14 | $1,107 | $79 |
| Irbesartan | 37 | $874 | $24 |
| Verapamil Er | 14 | $812 | $58 |
| Furosemide | 143 | $767 | $5 |
| Sotalol | 27 | $698 | $26 |
| Potassium Chloride | 30 | $650 | $22 |
| Losartan-Hydrochlorothiazide | 30 | $538 | $18 |
| Fosinopril | 13 | $524 | $40 |
| Simvastatin | 40 | $457 | $11 |
| Warfarin | 28 | $443 | $16 |
| Olmesartan Medoxomil | 17 | $430 | $25 |
| Olmesartan-Hydrochlorothiazide | 12 | $422 | $35 |
| Nitroglycerin | 14 | $389 | $28 |
| Doxazosin Mesylate | 12 | $370 | $31 |
| Pravastatin | 24 | $328 | $14 |
| Hydrochlorothiazide | 36 | $305 | $8 |
| Quinapril | 13 | $279 | $21 |
| Atenolol | 23 | $161 | $7 |
| Enalapril Maleate | 12 | $144 | $12 |
| Metoprolol | 20 | $140 | $7 |
| Clonidine | 13 | $96 | $7 |
| Ramipril | 12 | $72 | $6 |
2021: 49 drugs
| Eliquis | 278 | $323,246 | $1,163 |
| Xarelto | 194 | $221,148 | $1,140 |
| Entresto | 28 | $39,507 | $1,411 |
| Praluent | 42 | $24,139 | $575 |
| Multaq | 23 | $21,576 | $938 |
| Pradaxa | 19 | $17,051 | $897 |
| Repatha Sureclick | 27 | $15,488 | $574 |
| Bystolic | 29 | $11,119 | $383 |
| Vascepa | 14 | $10,273 | $734 |
| Diltiazem 24hr Er (Cd) | 94 | $9,757 | $104 |
| Brilinta | 12 | $9,475 | $790 |
| Metoprolol | 360 | $8,852 | $25 |
| Ranolazine Er | 30 | $8,508 | $284 |
| Ezetimibe | 120 | $8,104 | $68 |
| Propafenone | 87 | $7,925 | $91 |
| Rosuvastatin | 119 | $4,025 | $34 |
| Atorvastatin | 279 | $3,997 | $14 |
| Flecainide Acetate | 31 | $3,743 | $121 |
| Carvedilol | 204 | $2,837 | $14 |
| Amlodipine Besylate | 294 | $2,510 | $9 |
| Digoxin | 53 | $2,415 | $46 |
| Lisinopril | 153 | $2,371 | $15 |
| Losartan | 151 | $2,321 | $15 |
| Irbesartan | 31 | $2,165 | $70 |
| Hydralazine | 71 | $1,567 | $22 |
| Clopidogrel | 56 | $1,334 | $24 |
| Benazepril | 111 | $1,313 | $12 |
| Amiodarone | 64 | $1,210 | $19 |
| Isosorbide Mononitrate Er | 38 | $1,111 | $29 |
| Potassium Chloride | 38 | $1,078 | $28 |
| Sotalol | 25 | $1,053 | $42 |
| Irbesartan-Hydrochlorothiazide | 14 | $1,032 | $74 |
| Spironolactone | 57 | $983 | $17 |
| Furosemide | 141 | $874 | $6 |
| Quinapril | 18 | $746 | $41 |
| Verapamil Er | 14 | $701 | $50 |
| Pravastatin | 27 | $629 | $23 |
| Losartan-Hydrochlorothiazide | 20 | $610 | $31 |
| Diltiazem 24hr Er | 15 | $555 | $37 |
| Simvastatin | 46 | $539 | $12 |
| Nitroglycerin | 23 | $518 | $23 |
| Warfarin | 33 | $486 | $15 |
| Atenolol | 30 | $470 | $16 |
| Hydrochlorothiazide | 51 | $396 | $8 |
| Olmesartan Medoxomil | 13 | $307 | $24 |
| Enalapril Maleate | 12 | $257 | $21 |
| Ramipril | 21 | $203 | $10 |
| Metoprolol | 21 | $194 | $9 |
| Clonidine | 14 | $130 | $9 |
2020: 54 drugs
| Eliquis | 324 | $304,264 | $939 |
| Xarelto | 184 | $182,488 | $992 |
| Praluent | 57 | $41,763 | $733 |
| Entresto | 24 | $24,581 | $1,024 |
| Pradaxa | 24 | $20,985 | $874 |
| Brilinta | 25 | $16,943 | $678 |
| Repatha Sureclick | 29 | $14,295 | $493 |
| Bystolic | 41 | $13,204 | $322 |
| Ranolazine Er | 54 | $12,243 | $227 |
| Propafenone | 110 | $12,008 | $109 |
| Ezetimibe | 127 | $11,779 | $93 |
| Vascepa | 16 | $11,714 | $732 |
| Diltiazem 24hr Er (Cd) | 109 | $11,010 | $101 |
| Metoprolol | 353 | $8,644 | $24 |
| Rosuvastatin | 106 | $6,273 | $59 |
| Atorvastatin | 316 | $5,861 | $19 |
| Digoxin | 55 | $3,405 | $62 |
| Carvedilol | 246 | $2,876 | $12 |
| Amlodipine Besylate | 292 | $2,479 | $8 |
| Lisinopril | 179 | $2,476 | $14 |
| Losartan | 121 | $2,267 | $19 |
| Losartan-Hydrochlorothiazide | 20 | $2,247 | $112 |
| Hydralazine | 106 | $2,154 | $20 |
| Amiodarone | 91 | $2,042 | $22 |
| Flecainide Acetate | 16 | $1,689 | $106 |
| Benazepril | 133 | $1,661 | $12 |
| Irbesartan | 29 | $1,620 | $56 |
| Dilt-Xr | 13 | $1,297 | $100 |
| Clopidogrel | 83 | $1,249 | $15 |
| Sotalol | 34 | $1,128 | $33 |
| Isosorbide Mononitrate Er | 44 | $1,091 | $25 |
| Spironolactone | 58 | $994 | $17 |
| Potassium Chloride | 24 | $960 | $40 |
| Pravastatin | 40 | $920 | $23 |
| Warfarin | 59 | $885 | $15 |
| Furosemide | 119 | $797 | $7 |
| Diltiazem 24hr Er | 19 | $787 | $41 |
| Olmesartan Medoxomil | 15 | $778 | $52 |
| Cartia Xt | 18 | $778 | $43 |
| Valsartan | 11 | $754 | $69 |
| Nitroglycerin | 33 | $719 | $22 |
| Atenolol | 40 | $656 | $16 |
| Midodrine | 21 | $655 | $31 |
| Chlorthalidone | 32 | $640 | $20 |
| Verapamil Er | 15 | $609 | $41 |
| Ramipril | 25 | $434 | $17 |
| Simvastatin | 48 | $414 | $9 |
| Quinapril | 17 | $408 | $24 |
| Enalapril Maleate | 15 | $352 | $23 |
| Fosinopril | 12 | $339 | $28 |
| Hydrochlorothiazide | 39 | $316 | $8 |
| Metoprolol | 20 | $235 | $12 |
| Clonidine | 19 | $154 | $8 |
| Lisinopril-Hydrochlorothiazide | 11 | $138 | $13 |
2019: 53 drugs
| Eliquis | 326 | $257,132 | $789 |
| Xarelto | 148 | $136,388 | $922 |
| Praluent | 43 | $36,675 | $853 |
| Entresto | 32 | $24,706 | $772 |
| Pradaxa | 25 | $20,648 | $826 |
| Ranolazine Er | 39 | $15,717 | $403 |
| Vascepa | 24 | $14,013 | $584 |
| Ranexa | 24 | $11,360 | $473 |
| Bystolic | 27 | $10,956 | $406 |
| Propafenone | 94 | $10,500 | $112 |
| Repatha Sureclick | 22 | $10,241 | $465 |
| Brilinta | 18 | $10,220 | $568 |
| Metoprolol | 323 | $10,001 | $31 |
| Ezetimibe | 116 | $9,062 | $78 |
| Diltiazem 24hr Er (Cd) | 87 | $8,249 | $95 |
| Rosuvastatin | 93 | $7,593 | $82 |
| Atorvastatin | 293 | $5,589 | $19 |
| Edarbyclor | 13 | $4,634 | $356 |
| Amiodarone | 152 | $3,724 | $25 |
| Carvedilol | 240 | $3,535 | $15 |
| Amlodipine Besylate | 287 | $3,123 | $11 |
| Lisinopril | 182 | $2,706 | $15 |
| Hydralazine | 95 | $1,946 | $20 |
| Digoxin | 39 | $1,878 | $48 |
| Cartia Xt | 42 | $1,830 | $44 |
| Flecainide Acetate | 25 | $1,817 | $73 |
| Losartan | 119 | $1,719 | $14 |
| Sotalol | 46 | $1,630 | $35 |
| Benazepril | 124 | $1,467 | $12 |
| Warfarin | 67 | $1,274 | $19 |
| Dilt-Xr | 14 | $1,271 | $91 |
| Midodrine | 20 | $1,133 | $57 |
| Isosorbide Mononitrate Er | 63 | $1,133 | $18 |
| Irbesartan | 26 | $1,109 | $43 |
| Potassium Chloride | 19 | $1,037 | $55 |
| Clopidogrel | 70 | $1,016 | $15 |
| Furosemide | 124 | $1,008 | $8 |
| Diltiazem | 18 | $984 | $55 |
| Pravastatin | 35 | $887 | $25 |
| Toprol Xl | 19 | $863 | $45 |
| Diltiazem 24hr Er | 13 | $820 | $63 |
| Atenolol | 42 | $783 | $19 |
| Spironolactone | 59 | $774 | $13 |
| Chlorthalidone | 18 | $693 | $39 |
| Olmesartan Medoxomil | 16 | $689 | $43 |
| Simvastatin | 73 | $633 | $9 |
| Enalapril Maleate | 18 | $574 | $32 |
| Losartan-Hydrochlorothiazide | 35 | $537 | $15 |
| Nitroglycerin | 19 | $509 | $27 |
| Quinapril | 16 | $493 | $31 |
| Metoprolol | 33 | $446 | $14 |
| Ramipril | 19 | $363 | $19 |
| Hydrochlorothiazide | 26 | $186 | $7 |
2018: 55 drugs
| Eliquis | 246 | $155,393 | $632 |
| Xarelto | 143 | $111,733 | $781 |
| Ranexa | 74 | $42,442 | $574 |
| Entresto | 33 | $21,164 | $641 |
| Pradaxa | 29 | $17,862 | $616 |
| Repatha Sureclick | 14 | $15,811 | $1,129 |
| Metoprolol | 347 | $12,796 | $37 |
| Ezetimibe | 85 | $12,371 | $146 |
| Bystolic | 30 | $11,306 | $377 |
| Propafenone | 93 | $10,354 | $111 |
| Vascepa | 19 | $6,831 | $360 |
| Rosuvastatin | 97 | $6,113 | $63 |
| Atorvastatin | 269 | $4,799 | $18 |
| Diltiazem 24hr Er (Cd) | 88 | $4,351 | $49 |
| Carvedilol | 286 | $3,259 | $11 |
| Lisinopril | 218 | $2,877 | $13 |
| Amiodarone | 100 | $2,763 | $28 |
| Amlodipine Besylate | 266 | $2,727 | $10 |
| Cartia Xt | 63 | $2,460 | $39 |
| Isosorbide Mononitrate Er | 103 | $2,034 | $20 |
| Warfarin | 94 | $1,957 | $21 |
| Hydralazine | 93 | $1,698 | $18 |
| Flecainide Acetate | 12 | $1,524 | $127 |
| Losartan | 133 | $1,514 | $11 |
| Digoxin | 30 | $1,470 | $49 |
| Potassium Chloride | 26 | $1,415 | $54 |
| Chlorthalidone | 31 | $1,404 | $45 |
| Benazepril | 115 | $1,312 | $11 |
| Digox | 17 | $1,205 | $71 |
| Clopidogrel | 83 | $1,195 | $14 |
| Sotalol | 39 | $1,128 | $29 |
| Spironolactone | 80 | $928 | $12 |
| Furosemide | 132 | $846 | $6 |
| Simvastatin | 93 | $808 | $9 |
| Fenofibrate | 17 | $792 | $47 |
| Diltiazem | 25 | $780 | $31 |
| Atenolol | 43 | $779 | $18 |
| Dilt-Xr | 11 | $764 | $69 |
| Pravastatin | 26 | $740 | $28 |
| Irbesartan | 23 | $660 | $29 |
| Nitroglycerin | 36 | $626 | $17 |
| Valsartan | 20 | $613 | $31 |
| Spironolactone-Hctz | 15 | $595 | $40 |
| Quinapril | 21 | $584 | $28 |
| Enalapril Maleate | 12 | $522 | $43 |
| Metoprolol | 42 | $473 | $11 |
| Losartan-Hydrochlorothiazide | 34 | $454 | $13 |
| Ramipril | 35 | $440 | $13 |
| Amlodipine-Olmesartan | 11 | $399 | $36 |
| Diltiazem 24hr Er | 13 | $366 | $28 |
| Midodrine | 15 | $346 | $23 |
| Propranolol | 13 | $237 | $18 |
| Hydrochlorothiazide | 32 | $189 | $6 |
| Clonidine | 16 | $130 | $8 |
| Lisinopril-Hydrochlorothiazide | 13 | $93 | $7 |
2017: 54 drugs
| Eliquis | 241 | $115,168 | $478 |
| Xarelto | 157 | $83,021 | $529 |
| Pradaxa | 45 | $24,216 | $538 |
| Ranexa | 33 | $16,457 | $499 |
| Repatha Sureclick | 12 | $13,775 | $1,148 |
| Metoprolol | 386 | $11,028 | $29 |
| Brilinta | 24 | $10,461 | $436 |
| Bystolic | 42 | $9,832 | $234 |
| Zetia | 16 | $8,397 | $525 |
| Rosuvastatin | 63 | $5,395 | $86 |
| Propafenone | 90 | $5,364 | $60 |
| Ezetimibe | 22 | $4,595 | $209 |
| Atorvastatin | 215 | $3,891 | $18 |
| Amiodarone | 151 | $3,641 | $24 |
| Carvedilol | 363 | $3,161 | $9 |
| Lisinopril | 233 | $2,787 | $12 |
| Diltiazem 24hr Cd | 13 | $2,709 | $208 |
| Amlodipine Besylate | 255 | $2,237 | $9 |
| Diltiazem 24hr Er | 75 | $2,182 | $29 |
| Olmesartan Medoxomil | 14 | $2,053 | $147 |
| Cartia Xt | 62 | $1,767 | $28 |
| Valsartan | 44 | $1,765 | $40 |
| Potassium Chloride | 17 | $1,692 | $100 |
| Warfarin | 129 | $1,668 | $13 |
| Digox | 22 | $1,569 | $71 |
| Digoxin | 31 | $1,550 | $50 |
| Hydralazine | 86 | $1,316 | $15 |
| Benazepril | 136 | $1,180 | $9 |
| Flecainide Acetate | 20 | $1,162 | $58 |
| Isosorbide Mononitrate Er | 61 | $1,129 | $19 |
| Sotalol | 47 | $1,098 | $23 |
| Chlorthalidone | 26 | $1,081 | $42 |
| Losartan | 107 | $1,034 | $10 |
| Clopidogrel | 71 | $953 | $13 |
| Diltiazem | 29 | $937 | $32 |
| Furosemide | 165 | $810 | $5 |
| Spironolactone | 98 | $749 | $8 |
| Pravastatin | 43 | $721 | $17 |
| Metoprolol | 67 | $716 | $11 |
| Simvastatin | 90 | $638 | $7 |
| Nitroglycerin | 20 | $544 | $27 |
| Atenolol | 55 | $507 | $9 |
| Quinapril | 19 | $476 | $25 |
| Diltiazem Er | 15 | $455 | $30 |
| Ramipril | 38 | $442 | $12 |
| Hydrochlorothiazide | 47 | $362 | $8 |
| Valsartan-Hydrochlorothiazide | 17 | $340 | $20 |
| Fludrocortisone Acetate | 13 | $331 | $25 |
| Losartan-Hydrochlorothiazide | 43 | $329 | $8 |
| Midodrine | 14 | $245 | $17 |
| Enalapril Maleate | 12 | $202 | $17 |
| Omeprazole | 14 | $178 | $13 |
| Pantoprazole | 13 | $135 | $10 |
| Lisinopril-Hydrochlorothiazide | 17 | $65 | $4 |
2016: 53 drugs
| Eliquis | 160 | $73,706 | $461 |
| Xarelto | 104 | $44,081 | $424 |
| Zetia | 38 | $20,091 | $529 |
| Ranexa | 35 | $19,715 | $563 |
| Pradaxa | 37 | $17,023 | $460 |
| Brilinta | 40 | $13,005 | $325 |
| Crestor | 26 | $7,847 | $302 |
| Metoprolol | 295 | $7,654 | $26 |
| Bystolic | 42 | $6,853 | $163 |
| Benicar Hct | 12 | $4,584 | $382 |
| Amiodarone | 150 | $4,238 | $28 |
| Effient | 11 | $4,076 | $371 |
| Atorvastatin | 250 | $3,496 | $14 |
| Carvedilol | 432 | $3,350 | $8 |
| Benicar | 14 | $2,868 | $205 |
| Lisinopril | 245 | $2,542 | $10 |
| Valsartan | 37 | $2,397 | $65 |
| Amlodipine Besylate | 274 | $2,186 | $8 |
| Rosuvastatin | 24 | $2,133 | $89 |
| Propafenone | 71 | $1,989 | $28 |
| Digoxin | 58 | $1,976 | $34 |
| Warfarin | 149 | $1,786 | $12 |
| Nadolol | 14 | $1,352 | $97 |
| Diltiazem 24hr Er | 41 | $1,311 | $32 |
| Simvastatin | 119 | $1,207 | $10 |
| Sotalol | 48 | $1,200 | $25 |
| Benazepril | 155 | $1,197 | $8 |
| Cartia Xt | 33 | $1,120 | $34 |
| Flecainide Acetate | 26 | $1,000 | $38 |
| Ramipril | 31 | $991 | $32 |
| Clopidogrel | 63 | $957 | $15 |
| Benazepril-Hydrochlorothiazide | 11 | $927 | $84 |
| Hydralazine | 66 | $912 | $14 |
| Digox | 21 | $882 | $42 |
| Pravastatin | 44 | $805 | $18 |
| Metoprolol | 97 | $702 | $7 |
| Spironolactone | 113 | $682 | $6 |
| Diltiazem | 38 | $673 | $18 |
| Diltiazem 24hr Cd | 33 | $672 | $20 |
| Losartan | 86 | $658 | $8 |
| Isosorbide Mononitrate Er | 44 | $604 | $14 |
| Furosemide | 165 | $567 | $3 |
| Atenolol | 56 | $555 | $10 |
| Quinapril | 17 | $554 | $33 |
| Chlorthalidone | 11 | $540 | $49 |
| Potassium Chloride | 13 | $509 | $39 |
| Losartan-Hydrochlorothiazide | 65 | $450 | $7 |
| Hydrochlorothiazide | 81 | $445 | $5 |
| Enalapril Maleate | 14 | $362 | $26 |
| Verapamil Er | 12 | $290 | $24 |
| Valsartan-Hydrochlorothiazide | 13 | $229 | $18 |
| Nitrostat | 11 | $220 | $20 |
| Lisinopril-Hydrochlorothiazide | 11 | $32 | $3 |
2015: 47 drugs
| Eliquis | 135 | $51,120 | $379 |
| Xarelto | 108 | $44,775 | $415 |
| Zetia | 69 | $24,252 | $351 |
| Effient | 40 | $17,278 | $432 |
| Brilinta | 54 | $15,348 | $284 |
| Ranexa | 22 | $11,964 | $544 |
| Pradaxa | 18 | $10,253 | $570 |
| Crestor | 32 | $7,188 | $225 |
| Metoprolol | 232 | $6,005 | $26 |
| Bystolic | 38 | $5,744 | $151 |
| Amiodarone | 145 | $4,048 | $28 |
| Carvedilol | 424 | $3,042 | $7 |
| Valsartan | 36 | $2,931 | $81 |
| Digoxin | 80 | $2,865 | $36 |
| Benicar Hct | 11 | $2,794 | $254 |
| Atorvastatin | 210 | $2,782 | $13 |
| Benicar | 13 | $2,770 | $213 |
| Fenofibric Acid | 16 | $2,641 | $165 |
| Propafenone | 57 | $2,509 | $44 |
| Warfarin | 138 | $1,911 | $14 |
| Amlodipine Besylate | 273 | $1,784 | $7 |
| Diltiazem 24hr Cd | 69 | $1,743 | $25 |
| Diltiazem Er | 25 | $1,682 | $67 |
| Lisinopril | 214 | $1,595 | $7 |
| Digox | 28 | $1,585 | $57 |
| Pravastatin | 50 | $1,238 | $25 |
| Flecainide Acetate | 25 | $1,032 | $41 |
| Diltiazem 24hr Er | 35 | $914 | $26 |
| Cartia Xt | 27 | $874 | $32 |
| Simvastatin | 96 | $849 | $9 |
| Sotalol | 42 | $842 | $20 |
| Hydralazine | 69 | $840 | $12 |
| Benazepril | 142 | $813 | $6 |
| Metoprolol | 119 | $780 | $7 |
| Clopidogrel | 56 | $714 | $13 |
| Hydrochlorothiazide | 91 | $690 | $8 |
| Ramipril | 27 | $645 | $24 |
| Quinapril | 15 | $591 | $39 |
| Furosemide | 143 | $585 | $4 |
| Isosorbide Mononitrate Er | 31 | $451 | $15 |
| Atenolol | 56 | $431 | $8 |
| Losartan-Hydrochlorothiazide | 45 | $369 | $8 |
| Nitrostat | 20 | $331 | $17 |
| Spironolactone | 37 | $265 | $7 |
| Losartan | 34 | $215 | $6 |
| Lovastatin | 13 | $118 | $9 |
| Verapamil Er | 11 | $74 | $7 |
2014: 54 drugs
| Xarelto | 80 | $29,890 | $374 |
| Eliquis | 82 | $26,827 | $327 |
| Zetia | 57 | $19,731 | $346 |
| Effient | 55 | $15,716 | $286 |
| Ranexa | 16 | $9,979 | $624 |
| Diovan | 28 | $8,914 | $318 |
| Pradaxa | 14 | $7,130 | $509 |
| Metoprolol | 186 | $6,882 | $37 |
| Multaq | 15 | $6,742 | $449 |
| Brilinta | 25 | $5,837 | $233 |
| Bystolic | 46 | $5,124 | $111 |
| Benicar | 30 | $4,872 | $162 |
| Carvedilol | 439 | $4,726 | $11 |
| Crestor | 20 | $4,395 | $220 |
| Atorvastatin | 150 | $3,829 | $26 |
| Valsartan | 17 | $2,910 | $171 |
| Propafenone | 60 | $2,647 | $44 |
| Digoxin | 64 | $2,574 | $40 |
| Digox | 59 | $2,518 | $43 |
| Amiodarone | 94 | $2,513 | $27 |
| Amlodipine Besylate | 269 | $2,471 | $9 |
| Vytorin | 12 | $2,270 | $189 |
| Lisinopril | 209 | $2,228 | $11 |
| Warfarin | 155 | $2,196 | $14 |
| Micardis | 11 | $1,779 | $162 |
| Hydralazine | 90 | $1,779 | $20 |
| Diltiazem 24hr Cd | 72 | $1,619 | $22 |
| Pravastatin | 58 | $1,601 | $28 |
| Simvastatin | 144 | $1,529 | $11 |
| Diltiazem 24hr Er | 49 | $1,376 | $28 |
| Diltiazem Er | 19 | $1,283 | $68 |
| Sotalol | 16 | $956 | $60 |
| Flecainide Acetate | 25 | $954 | $38 |
| Perindopril Erbumine | 15 | $921 | $61 |
| Potassium Chloride | 20 | $918 | $46 |
| Benazepril | 116 | $892 | $8 |
| Cartia Xt | 23 | $853 | $37 |
| Quinapril | 11 | $767 | $70 |
| Metoprolol | 105 | $733 | $7 |
| Clopidogrel | 54 | $709 | $13 |
| Ramipril | 27 | $611 | $23 |
| Losartan | 57 | $581 | $10 |
| Hydrochlorothiazide | 88 | $575 | $7 |
| Furosemide | 152 | $571 | $4 |
| Spironolactone | 62 | $535 | $9 |
| Atenolol | 45 | $501 | $11 |
| Verapamil Er | 22 | $437 | $20 |
| Isosorbide Mononitrate Er | 24 | $336 | $14 |
| Losartan-Hydrochlorothiazide | 25 | $321 | $13 |
| Nitrostat | 21 | $281 | $13 |
| Lovastatin | 27 | $279 | $10 |
| Fosinopril | 11 | $151 | $14 |
| Lisinopril-Hydrochlorothiazide | 13 | $101 | $8 |
| Allopurinol | 11 | $50 | $5 |
2013: 53 drugs
| Xarelto | 54 | $21,515 | $398 |
| Diovan | 57 | $15,000 | $263 |
| Zetia | 58 | $12,991 | $224 |
| Pradaxa | 20 | $8,744 | $437 |
| Metoprolol | 223 | $8,628 | $39 |
| Eliquis | 23 | $6,203 | $270 |
| Brilinta | 25 | $6,170 | $247 |
| Ranexa | 15 | $6,143 | $410 |
| Crestor | 23 | $5,707 | $248 |
| Effient | 21 | $4,821 | $230 |
| Carvedilol | 330 | $4,259 | $13 |
| Atorvastatin | 102 | $4,070 | $40 |
| Propafenone | 54 | $3,923 | $73 |
| Benicar Hct | 12 | $3,856 | $321 |
| Bystolic | 46 | $3,684 | $80 |
| Welchol | 12 | $3,571 | $298 |
| Clopidogrel | 107 | $3,466 | $32 |
| Vytorin | 14 | $3,204 | $229 |
| Amlodipine Besylate | 279 | $3,128 | $11 |
| Warfarin | 192 | $1,993 | $10 |
| Lisinopril | 163 | $1,803 | $11 |
| Simvastatin | 151 | $1,784 | $12 |
| Micardis | 12 | $1,624 | $135 |
| Amiodarone | 92 | $1,372 | $15 |
| Amlodipine Besylate-Benazepril | 16 | $1,363 | $85 |
| Hydralazine | 63 | $1,290 | $20 |
| Diltiazem 24hr Er | 37 | $1,251 | $34 |
| Losartan | 73 | $1,236 | $17 |
| Verapamil Er | 28 | $1,114 | $40 |
| Metoprolol | 123 | $1,043 | $8 |
| Perindopril Erbumine | 20 | $947 | $47 |
| Digox | 100 | $933 | $9 |
| Benazepril | 99 | $880 | $9 |
| Diltiazem 24hr Cd | 26 | $847 | $33 |
| Quinapril | 11 | $812 | $74 |
| Potassium Chloride | 37 | $794 | $21 |
| Sotalol | 18 | $718 | $40 |
| Spironolactone | 62 | $666 | $11 |
| Cartia Xt | 14 | $660 | $47 |
| Ramipril | 26 | $636 | $24 |
| Pravastatin | 36 | $628 | $17 |
| Losartan-Hydrochlorothiazide | 23 | $617 | $27 |
| Hydrochlorothiazide | 83 | $609 | $7 |
| Furosemide | 138 | $531 | $4 |
| Atenolol | 30 | $440 | $15 |
| Nitrostat | 33 | $408 | $12 |
| Isosorbide Mononitrate Er | 28 | $383 | $14 |
| Digoxin | 38 | $361 | $10 |
| Lovastatin | 25 | $334 | $13 |
| Pacerone | 16 | $302 | $19 |
| Fosinopril | 16 | $229 | $14 |
| Levothyroxine | 14 | $199 | $14 |
| Allopurinol | 16 | $72 | $5 |
Money from drug and device companies
$1,575 in 2025
| 2025 | 12 | 41 | None | $1,575 |
| 2024 | 12 | 58 | None | $1,201 |
| 2023 | 11 | 61 | None | $1,139 |
| 2022 | 11 | 56 | None | $1,488 |
| 2021 | 16 | 64 | None | $1,654 |
| 2020 | 11 | 28 | None | $595 |
| 2019 | 16 | 125 | None | $1,790 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | None | $538 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $245 | 14 payments
|
| Biotronik | Solia | $167 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $118 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $100 | 4 payments
|
| Actelion Pharmaceuticals US | Opsumit | $94 | 3 payments
|
See all 41 published payments
| Medtronic | Travel · 2025-11-26 | None | $100 |
| Medtronic | Travel · 2025-11-24 | None | $438 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-14 | Kerendia | $29 |
| Octapharma USA | Meals · 2025-11-14 | Balfaxar | $16 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-10 | Eliquis | $11 |
| Actelion Pharmaceuticals US | Meals · 2025-11-07 | Opsynvi | $34 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-31 | Farxiga | $28 |
| Pfizer | Meals · 2025-10-17 | Eliquis | $23 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-10 | Eliquis | $35 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-26 | Kerendia | $24 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-25 | Camzyos | $18 |
| Merck Sharp & Dohme | Meals · 2025-09-19 | Verquvo | $14 |
| Biotronik | Meals · 2025-09-18 | Solia | $167 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-12 | Eliquis | $26 |
| Amgen | Meals · 2025-08-22 | Repatha | $26 |
| Merck Sharp & Dohme | Meals · 2025-08-08 | Verquvo | $29 |
| Boston Scientific | Meals · 2025-08-01 | Watchman Flx | $30 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-24 | Eliquis | $13 |
| Actelion Pharmaceuticals US | Meals · 2025-07-12 | Opsumit | $27 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-06 | Camzyos | $5 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-30 | Eliquis | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-23 | Farxiga | $24 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-23 | Kerendia | $17 |
| Actelion Pharmaceuticals US | Meals · 2025-05-17 | Opsumit | $33 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-02 | Jardiance | $33 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-25 | Eliquis | $11 |
| Merck Sharp & Dohme | Meals · 2025-04-18 | Verquvo | $21 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-11 | Eliquis | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-11 | Farxiga | $25 |
| Amgen | Meals · 2025-04-04 | Repatha | $29 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-03 | Camzyos | $10 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-18 | Eliquis | $7 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-03-14 | Kerendia | $28 |
| Boston Scientific | Meals · 2025-03-08 | Watchman Flx | $26 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-21 | Camzyos | $30 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-12 | Farxiga | $22 |
| Pfizer | Meals · 2025-01-31 | Eliquis | $28 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-01-24 | Kerendia | $20 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-23 | Camzyos | $20 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-01-10 | Jardiance | $39 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-06 | Camzyos | $10 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,201
| AstraZeneca Pharmaceuticals LP | Farxiga | $210 | 9 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $181 | 9 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $153 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $152 | 18 payments
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $117 | 5 payments
|
| Boston Scientific | Watchman Flx | $108 | 4 payments
|
| Merck Sharp & Dohme | Verquvo | $101 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $68 | 3 payments
|
| Amgen | Repatha | $50 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $25 | 1 payment
|
| Heartflow | Ffrct | $23 | 1 payment
|
| Pfizer | Eliquis | $14 | 1 payment
|
2023: $1,139
| Merck Sharp & Dohme | Verquvo | $363 | 11 payments
|
| Novartis Pharmaceuticals | Leqvio | $231 | 21 payments
|
| Amgen | Repatha | $132 | 9 payments
|
| Janssen Pharmaceuticals | Xarelto | $102 | 6 payments
|
| Pfizer | Eliquis | $84 | 4 payments
|
| Boston Scientific | Watchman Flx | $44 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $42 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $42 | 2 payments
|
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $41 | 2 payments
|
| Actelion Pharmaceuticals US | Opsumit | $32 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $26 | 1 payment
|
2022: $1,488
| Boston Scientific | Watchman Access System | $422 | 9 payments
|
| Merck Sharp & Dohme | Verquvo | $248 | 9 payments
|
| Novartis Pharmaceuticals | Entresto | $197 | 16 payments
|
| Biotronik | Biomonitor | $159 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $146 | 6 payments
|
| Amgen | Repatha | $122 | 6 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $81 | 4 payments
|
| Sanofi-Aventis U.S. | Multaq | $45 | 2 payments
|
| Actelion Pharmaceuticals US | Opsumit | $34 | 1 payment
|
| Pfizer | Eliquis | $19 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $16 | 1 payment
|
2021: $1,654
| Boston Scientific | Watchman | $451 | 13 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $187 | 6 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $181 | 5 payments
|
| Janssen Pharmaceuticals | Xarelto | $168 | 8 payments
|
| Amgen | Repatha | $143 | 6 payments
|
| Novartis Pharmaceuticals | Entresto | $117 | 7 payments
|
| Merck Sharp & Dohme | Verquvo | $87 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $82 | 4 payments
|
| Abbott Laboratories | Mitraclip System | $49 | 2 payments
|
| Arbor Pharmaceuticals | Edarbyclor | $47 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $32 | 2 payments
|
| Alnylam Pharmaceuticals | Onpattro | $28 | 1 payment
|
| Esperion Therapeutics | Nexletol | $26 | 1 payment
|
| Amarin Pharma | Vascepa | $20 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $19 | 1 payment
|
| Amryt Pharma Holdings | Juxtapid | $16 | 1 payment
|
2020: $595
| Janssen Pharmaceuticals | Xarelto | $110 | 6 payments
|
| Sanofi-Aventis U.S. | Multaq | $71 | 4 payments
|
| Amgen | Repatha | $69 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $66 | 3 payments
|
| Boston Scientific | Watchman | $66 | 3 payments
|
| Regeneron Healthcare Solutions | Praluent | $63 | 2 payments
|
| Esperion Therapeutics | Nexletol | $42 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $37 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $24 | 1 payment
|
| Amarin Pharma | Vascepa | $24 | 1 payment
|
| GlaxoSmithKline | Anoro Ellipta | $22 | 1 payment
|
2019: $1,790
| Janssen Pharmaceuticals | Xarelto | $277 | 14 payments
|
| Boehringer Ingelheim Pharmaceuticals | Pradaxa | $207 | 28 payments
|
| Amgen | Repatha | $184 | 11 payments
|
| Arbor Pharmaceuticals | Edarbyclor | $172 | 21 payments
|
| Sanofi-Aventis U.S. | Praluent | $165 | 7 payments
|
| Novartis Pharmaceuticals | Entresto | $160 | 11 payments
|
| Regeneron Healthcare Solutions | Praluent | $142 | 14 payments
|
| Abiomed | Impella | $125 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $124 | 6 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $59 | 3 payments
|
| Relypsa | Veltassa | $56 | 3 payments
|
| Abbott Laboratories | Mitra Clip System | $28 | 2 payments
|
| Allergan | Bystolic | $25 | 1 payment
|
| Amarin Pharma | Vascepa | $25 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $24 | 1 payment
|
| GlaxoSmithKline | Anoro | $17 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 22.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1558471540
- Licence
- CA A50724California A50724: Current · expires 2027-10-31
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00A507241
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- 18550 De Paul Drive, Suite 107, Morgan Hill, CA, 95037
- NPI first listed
- 2006-08-30
- NPI last updated
- 2007-11-28
This is when the NPI record was last certified, not a medical board exam.